Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain-Healthy diet tested in ALS and Parkinson's patients

NCT ID NCT07625605

First seen Jun 09, 2026 · Last updated Jun 23, 2026 · Updated 4 times

Summary

This completed study tested whether people with ALS or Parkinson's disease can follow the MIND diet, a brain-healthy eating plan. 43 participants received a cookbook, educational materials, and weekly tips. Researchers tracked diet adherence, gut bacteria, and blood markers to see if the diet is practical and might affect inflammation or metabolism. The goal was to gather initial data, not to prove the diet treats these diseases.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Gary E Shealy Memorial ALS Clinic

    Elizabethton, Tennessee, 37643, United States

  • The Cole Center for Parkinson's & Movement Disorders

    Knoxville, Tennessee, 37922, United States

  • University Neurology

    Knoxville, Tennessee, 37920, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

MIND diet (a hybrid of Mediterranean and DASH diets)

What this could lead to

If the diet proves feasible and shows positive effects on gut health or inflammation, it could point toward a supportive dietary strategy for people with ALS or Parkinson's.

What could go wrong

This is a small, early feasibility study with only 43 participants and no control group. It cannot prove the diet slows or treats the diseases, and results may not apply to everyone.

Conditions

The condition(s) this trial relates to.

amyotrophic lateral sclerosis Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.